Northstar Neuroscience, Inc. (NASDAQ: NSTR), a developer of medical devices for the treatment of neurological diseases and disorders, announced that long-term data for both the PROSPECT feasibility study of cortical stimulation for depression and the EVEREST pivotal trial studying cortical stimulation for arm/hand disability post stroke were presented this week at the American Society for Stereotactic and Functional Neurosurgery (ASSFN) meeting in Vancouver, British Columbia.
Popularity: 1% [?]
Related posts:
- Northstar Neuroscience Receives FDA Approval For A Clinical Study Of Its Cortical Stimulation System For The Treatment Of Major Depressive Disorder
- Northstar Neuroscience Receives FDA Approval For A Clinical Study Of Its Cortical Stimulation System For The Treatment Of Major Depressive Disorder
- In Short And Long Term, Psychosocial Therapy With Antidepressants More Effective In Helping Depressed Stroke Patients
- Women More Likely Than Men To Suffer Depression After Stroke
- New Pacemaker-Like Device Offers Hope To Those Living With Treatment-Resistant Depression
Comments
No Responses to “Northstar Neuroscience Announces Presentation Of Long-Term Data Of Cortical Stimulation For Depression And Stroke Recovery”